Access
To read this article in full you will need to log-in or choose from the options on the right.
Distillery: Therapeutics - Cancer
SciBX 1(8); doi:10.1038/scibx.2008.183
Published online March 20 2008
Extra navigation
p53; MDM2
An in vitro and in vivo study suggests that MI-219, a spirooxindole compound, could help activate p53 and thus be useful for treating cancer. Further details on the research, next steps and licensing status are discussed in the article.
To read this article in full you will need to log-in or choose from the options on the right.
